US$ 25.10
glp-1 agonists for type 2 diabetes New Developments in Pharmacological Treatment of Obesity and Diabetes—Beyond and within Receptor GLP-1 Receptor Agonists as Treatments
Description
2025;3(7):luaf104

The active ingredient in Trulicity is dulaglutide, which is different than semaglutide

Principally used in the management of type 2 diabetes mellitus (T2DM) and obesity, recent work posits a broader role of the peptide in modulating numerous physiologic pathways [11, 12]

Not on ten-panel screens

Then some charge a monthly fee for follow-ups, as well as a monthly cost for the prescription